PF-06671008

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06671008, covering 2020-05-06 to 2020-05-06. Get the full timeline:

Most recent: Clinical Trial Update: PF-06671008 Dose Escalation Study in Advanced Solid Tumors [Phase 1]